Transdermal Therapeutics is a compound pharmacy committed to providing prescribers the highest quality customized pain management medications for their patients.
It is our vision to continue providing effective non addictive pain solutions for patients and prescribers. In addition, we are partnering with the medical community through focused research and discovery of additional solutions for patients who suffer with debilitating pain, while maintaining a safe, cost effective treatment option.
Company Details
- Employees
- 56
- Founded
- -
- Address
- 211 Summit Parkway,
- Phone
- +1 877 581 5444
- in****@****inc.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- transdermalinc.com
- Keywords
- Superior non addictive pain management creams, User friendly, Patient preferred, Primary Care, Orthopedics, Rheumatology, Podiatry, Pain Management, Neurology.
- HQ
- Birmingham, AL
Transdermal Therapeutics Questions
Transdermal Therapeutics's helpline number is +1 877 581 5444
Transdermal Therapeutics's website is transdermalinc.com
Transdermal Therapeutics's LinkedIn profile is https://www.linkedin.com/company/transdermal-therapeutics
Transdermal Therapeutics has
56 employees.
View email and phone details for 56
employees at Transdermal Therapeutics.
Transdermal Therapeutics's industry is
Pharmaceutical Manufacturing
Transdermal Therapeutics's top competitors are
Kenox Pharmaceuticals, Inc,
Scarlet Therapeutics Ltd,
Ensilitech,
Cypert Insurance,
Microneedles Inc.,
Compound Pharmaceutical Technologies, Inc.,
Skinport Microneedles,
Transdermal Diagnostics Ltd,
Beijing Cas Microneedle Technology, Ltd.,
Trpl, Llc.
Transdermal Therapeutics's support email address is info@transdermalinc.com
Transdermal Therapeutics's categories are Pharmaceutical Manufacturing
Transdermal Therapeutics's founding year is 2010
